Clinical utility of serial systemic immune inflammation indices (SSIIi) in the context of post covid-19 neurological syndrome (PCNS)

J Neurol Sci. 2021 Apr 15:423:117356. doi: 10.1016/j.jns.2021.117356. Epub 2021 Feb 20.

Authors

Tissa Wijeratne¹, Chanith Wijeratne²

Affiliations

¹ School of Psychology and Public Health, La Trobe University, Melbourne, Australia; Department of Neurology, Western Health & University Melbourne, AIMSS, Level three, WHCRE, Sunshine Hospital, St Albans, 3021, Australia; Department of Medicine, Faculty of Medicine, University of Rajarata, Saliyapura, Anuradhapura, Sri Lanka.. Electronic address: tissa.wijeratne@wh.org.au.
² Monash Medical School, Clayton, Victoria, Australia.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Blood Cell Count*
Brain Ischemia / blood
Brain Ischemia / etiology
COVID-19 / complications*
Disease Progression
Humans
Male
SARS-CoV-2*
Severity of Illness Index*
Syndrome
Systemic Inflammatory Response Syndrome / blood*
Systemic Inflammatory Response Syndrome / etiology